Correlation of Vitamin D Deficiency With Severity of Chronic Heart Failure as Assessed by Functional Class and N-Terminal Pro-Brain Natriuretic Peptide Levels.
heart failure
nt-pro bnp
severity
vitamin-d deficiency
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
23 Feb 2021
23 Feb 2021
Historique:
entrez:
31
3
2021
pubmed:
1
4
2021
medline:
1
4
2021
Statut:
epublish
Résumé
Introduction Chronic heart failure (CHF) is a major cause of mortality and morbidity in spite of tremendous advances in medical therapies. Vitamin D deficiency has been increasingly recognised in heart failure and its therapeutic as well as prognostic implications are debated. This study was carried out to examine the relationship of Vitamin D levels with severity of heart failure as assessed by NYHA functional class and serum N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels in vitamin D deficient patients with CHF. Methodology and results In this cross-sectional analysis, 119 patients of symptomatic CHF presenting to the outpatient/inpatient department of cardiology in a tertiary care institute in North India were screened. Patients were categorised according to their functional class as New York Heart Association (NYHA) class II, III, IV and their serum levels of vitamin D and NT-pro-BNP were measured. Out of 119 patients, 107 (90%) were found to have low vitamin D levels which were classified as insufficient (20-30 ng/ml) (n=25, 23%) or deficient (<20 ng/ml) (n=82,77%). The mean NT-pro-BNP levels increased significantly across functional class as 3783±6132 pg/ml, 7866±4383 pg/ml, 21115±11905 pg/ml in NYHA class II, III and IV respectively (p=0.000). The respective mean serum Vitamin D3 levels of 11.6±5.8ng/ml, 12.2±7.9 ng/ml, 14.4±8.9 ng/ml were not significantly different between classes (p=0.234). We found no correlation between serum NT-pro-BNP and serum vitamin D levels in the study cohort across various NYHA classes. In multivariate regression model, after adjusting for various co-variates, vitamin D levels were not significantly associated with NT-pro-BNP or functional class in patients with CHF. Conclusion Patients with CHF have a high prevalence (90%) of vitamin D deficiency. Although NT-pro-BNP levels increase significantly, vitamin D levels do not vary significantly with worsening NYHA classes. Further, no consistent significant correlation of vitamin D deficiency with NT-pro-BNP across different NYHA classes was observed. Thus, low levels of vitamin D didn't predict the severity and prognosis of patients with heart failure. .
Identifiants
pubmed: 33786229
doi: 10.7759/cureus.13522
pmc: PMC7996472
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e13522Informations de copyright
Copyright © 2021, Otaal et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Rev Cardiol. 2016 Jun;13(6):368-78
pubmed: 26935038
JACC Heart Fail. 2015 May;3(5):347-356
pubmed: 25863973
Eur J Heart Fail. 2011 Jun;13(6):619-25
pubmed: 21543375
Eur J Heart Fail. 2011 Jun;13(6):626-32
pubmed: 21415099
South Med J. 2008 Sep;101(9):906-9
pubmed: 18708969
Heart Lung. 2002 Jul-Aug;31(4):262-70
pubmed: 12122390
Am J Cardiol. 2010 Oct 1;106(7):963-8
pubmed: 20854958
Circulation. 2008 Jan 29;117(4):503-11
pubmed: 18180395
J Family Med Prim Care. 2018 Mar-Apr;7(2):324-330
pubmed: 30090772
Sci Rep. 2018 Jan 18;8(1):1169
pubmed: 29348609
Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E125-32
pubmed: 15367398
Atherosclerosis. 2009 Jul;205(1):255-60
pubmed: 19091317
Am J Med Sci. 2008 Apr;335(4):292-7
pubmed: 18414068
J Clin Invest. 2002 Jul;110(2):229-38
pubmed: 12122115
Dis Markers. 2016;2016:3970284
pubmed: 26955207
J Am Coll Cardiol. 2017 Nov 14;70(20):2476-2486
pubmed: 29141781
J Int Med Res. 2004 Nov-Dec;32(6):570-82
pubmed: 15587751
J Am Coll Cardiol. 2016 Jun 7;67(22):2593-603
pubmed: 27058906
Eur Heart J. 2017 Aug 1;38(29):2279-2286
pubmed: 28498942
Adv Biomed Res. 2014 Dec 31;3:261
pubmed: 25625100
Cardiovasc Pathol. 2012 Sep-Oct;21(5):365-71
pubmed: 22227365
EJIFCC. 2013 Feb 21;24(3):78-84
pubmed: 27683441
N Am J Med Sci. 2013 Apr;5(4):266-79
pubmed: 23724401
Circulation. 2004 Oct 12;110(15):2168-74
pubmed: 15451800
J Clin Endocrinol Metab. 2008 Oct;93(10):3927-35
pubmed: 18682515
Am J Cardiol. 2010 Sep 15;106(6):798-805
pubmed: 20816120
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
J Am Coll Cardiol. 2003 Jan 1;41(1):105-12
pubmed: 12570952
Am J Cardiol. 2008 Dec 1;102(11):1540-4
pubmed: 19026311
Am J Clin Nutr. 2006 Apr;83(4):754-9
pubmed: 16600924